Long-term outcomes after microvascular decompression for glossopharyngeal neuralgia

Neurosurg Focus 59(3):E19, 2025

Microvascular decompression (MVD) without neurectomy is effective and safe for glossopharyngeal neuralgia (GPN), with 86% long-term pain freedom and minimal complications. Pain location or radiation did not affect outcomes. Redo MVD is effective for persistent neurovascular compression. High-resolution MRI is useful for preoperative assessment.

• Microvascular decompression (MVD) without neurectomy is effective for glossopharyngeal neuralgia (GPN), including redo procedures.

• In a cohort of 29 patients, 86% were pain free at long-term follow-up (mean 65.3 months); 83% were immediately pain free post-op.

• Complication rates were low: 10% immediate and 11% long-term, with mostly mild symptoms.

• Redo MVD was successful in 3 out of 4 patients with persistent neurovascular compression after prior procedures.

• Pain location or direction of radiation did not affect pain outcomes after MVD.

• Most patients had neurovascular compression (NVC) visible on preoperative MRI, commonly involving the posterior inferior cerebellar artery (PICA).

• MVD is effective even in elderly patients and those with failed prior treatments, provided NVC is present.

• Findings support MVD as a primary treatment for classical GPN, guiding patient selection and management.